Family Impact, Caregiver Burden, Parental Monitoring, and Glycemic Control in Children with Type 1 Diabetes: A Cross-Sectional Study
Abstract
Highlights What are the main findings? Greater parental monitoring was associated with lower HbA1c, including after adjustment for perceived household financial adequacy and in the age-restricted sensitivity analysis. Families reporting income below expenses had higher HbA1c levels and greater diabetes-specific family impact and caregiver burden than financially balanced families. What are the implications of the main findings? Parental monitoring and household socioeconomic circumstances should both be considered when evaluating glycemic and family-related outcomes in pediatric type 1 diabetes. Family-centered assessment may help identify families experiencing greater diabetes-related impact and caregiver burden, particularly those reporting financial strain. Abstract Objectives: To examine the association between family-related psychosocial factors and glycemic control in children with type 1 diabetes. Methods: This cross-sectional study included 67 children with type 1 diabetes and their parents. Data were collected using the Diabetes Family Impact Scale, Caregiver Burden Scale, and Parental Monitoring of Diabetes Care Scale. Sociodemographic and clinical variables, including glycated hemoglobin (HbA1c) levels, were recorded. Spearman correlation analyses and multivariable regression models were performed. Results: A total of 67 parent–child dyads were included. Diabetes-specific family impact was strongly correlated with caregiver burden (ρ = 0.617, p < 0.001).…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 67 participants or records.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.